Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
12.57
+0.29 (2.36%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eton Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for ETON stock have an average target of 15, which predicts an increase of 19.33% from the current stock price of 12.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ETON stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 → $15 | Strong Buy | Reiterates | $11 → $15 | +19.33% | Nov 26, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | -12.49% | Nov 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +19.33% | Oct 28, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | -20.45% | Oct 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | -12.49% | Oct 4, 2024 |
Financial Forecast
Revenue This Year
38.94M
from 31.64M
Increased by 23.05%
Revenue Next Year
70.58M
from 38.94M
Increased by 81.27%
EPS This Year
-0.13
from -0.04
EPS Next Year
0.46
from -0.13
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 40.6M | 77.1M | 98.4M | |||
| Avg | 38.9M | 70.6M | 95.6M | |||
| Low | 36.9M | 63.7M | 91.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 28.2% | 97.9% | 39.4% | |||
| Avg | 23.1% | 81.3% | 35.5% | |||
| Low | 16.8% | 63.6% | 30.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.11 | 0.49 | 0.89 | |||
| Avg | -0.13 | 0.46 | 0.87 | |||
| Low | -0.15 | 0.43 | 0.83 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 92.3% | |||
| Avg | - | - | 86.8% | |||
| Low | - | - | 79.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.